Skip to main content
. 2020 Jul 17;40(7):BSR20200995. doi: 10.1042/BSR20200995

Table 6. Summary of different comparative results for MTHFR C677T polymorphisms in ovarian cancer.

Genotypes Overall and subgroup Participants OR and 95%CI Z value P value I2 (%) Effect model#
TT vs. CT+ CC Overall 12,700 1.11 [0.88, 1.41] 0.87 0.39 61 R
Asian 1,455 2.35 [1.59, 3.48] 4.3 0.01 0 F
Caucasian 11,141 1.82 [0.85, 3.93] 0.72 0.47 16 F
TT+ CT vs. CC Overall 12,700 1.06 [0.99, 1.15] 1.58 0.11 49 F
Asian 1,455 1.49 [1.19, 1.86] 3.44 0.01 3 F
Caucasian 11,141 1.02 [0.94, 1.10] 0.46 0.64 32 F
CT vs. CC+ TT Overall 12,700 1.05 [0.97, 1.13] 1.17 0.24 0 F
Asian 1,455 1.11 [0.88, 1.39] 0.89 0.37 0 F
Caucasian 11,141 1.04 [0.96, 1.13] 0.92 0.36 22 F
TT vs. CC Overall 7,150 1.18 [0.89, 1.55] 1.16 0.24 68 R
Asian 915 2.84 [1.88, 4.31] 4.93 0.01 0 F
Caucasian 6,199 0.97 [0.85, 1.11] 0.41 0.68 25 F
T vs. C Overall 25,400 1.08 [0.96, 1.21] 1.31 0.19 66 R
Asian 2,910 1.49 [1.26, 1.77] 4.6 0.01 10 F
Caucasian 22,282 1.00 [0.94, 1.06] 0 1 29 F
#

Effect model includes fixed-effect model (F) and random-effect model (R).